Showing results (481-490 of 496) with videos related to

Sort By:
Pageof 50
International Journal of Cancer|December 22, 2021
Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinomaEvelien J M de Jong, Quisette P Janssen, Tessa F A Simons, et al.
Plos One|January 25, 2023
Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional studyFriso B Achterberg, Babs G Sibinga Mulder, Quisette P Janssen, et al.
Vox Sanguinis|March 25, 2025
Clinical evaluation of red cell concentrates in non-DEHP plasticized containers compared with standard DEHP plasticized containers: A quasi-randomized observational multicentre studyChristie Vermeulen, Nan van Geloven, Bart Mertens, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 29, 2016
Cardiovascular malformations caused by NOTCH1 mutations do not keep left: data on 428 probands with left-sided CHD and their familiesWilhelmina S Kerstjens-Frederikse, Ingrid M B H van de Laar, Yvonne J Vos, et al.
BMC Cancer|March 24, 2021
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trialQ P Janssen, J L van Dam, B A Bonsing, et al.
Annals of Surgery|February 12, 2026
Staging Laparoscopy After Neoadjuvant Treatment for Pancreatic Cancer to Prevent Non-Therapeutic Laparotomy: Analysis in the PREOPANC-2 Randomized TrialIngmar F Rompen, Esther N Dekker, Thomas F Stoop, et al.
Annals of Surgical Oncology|December 20, 2022
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort StudyEran van Veldhuisen, Sjors Klompmaker, Quisette P Janssen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 7, 2023
Diagnostic accuracy of endoscopic ultrasonography-guided tissue acquisition prior to resection of pancreatic carcinoma: a nationwide analysisRutger Quispel, Hannah M Schutz, Augustinus W P Keultjes, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
Annals of Surgery|August 12, 2025
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled TrialEsther N Dekker, Rutger T Theijse, Jacob L van Dam, et al.
Pageof 50